Generation Bio Co.
GBIO
$5.23
$0.122.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.62% | -41.35% | 30.77% | -39.63% | 25.05% |
| Total Depreciation and Amortization | 23.81% | -0.18% | -3.40% | -0.34% | -6.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,981.07% | -45.41% | -59.26% | 111.71% | -22.03% |
| Change in Net Operating Assets | -1,580.93% | 110.58% | -1,825.94% | 88.95% | -41.99% |
| Cash from Operations | -213.05% | 40.66% | -79.68% | 19.25% | 9.23% |
| Capital Expenditure | 100.00% | -86.59% | 34.92% | -315.38% | -550.00% |
| Sale of Property, Plant, and Equipment | 18.14% | 580.00% | -36.17% | 4.44% | -56.73% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.30% | 379.23% | -95.51% | 453.67% | 6.28% |
| Cash from Investing | 70.74% | 405.61% | -95.79% | 453.07% | 5.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | 1,115.38% | -95.09% |
| Repurchase of Common Stock | -100.00% | 85.71% | 50.00% | 12.50% | 48.39% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.50% | 1,242.86% | -104.86% | 4,900.00% | -101.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,411.07% | 92.93% | -146.50% | 898.66% | 25.72% |